Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Is Abbott Wavering Over Alere?

This article was originally published in Clinica

Executive Summary

A non-committal response from Abbott Labs CEO Miles White about the progress of the company’s proposed acquisition of Alere, which is in the midst of a federal investigation over potentially corrupt sales practices abroad, has raised doubts about the $5.8bn transaction. White’s refusal to reaffirm the diagnostic giant’s commitment to the deal slightly eclipsed the positive financial figures it posted for the first quarter this year.